Tilray Brands Inc. shares rose 2.23% to $4.12 in after-hours trading on Wednesday after the company reported fourth-quarter revenue that topped analyst estimates. The cannabis and beverage conglomerate posted Q4 net revenue of $281.7 million for the period ended May 31, surpassing the consensus estimate of $254.53 million by 10.7%. This positive revenue surprise drove the immediate market reaction, although earnings per share (EPS) of $0.05 missed the $0.21 consensus estimate by 76.2%.

The quarterly results contributed to a strong full fiscal year performance for Tilray Brands. For fiscal year 2026, the company delivered record net revenue of $915.5 million, an 11% increase from $821.3 million in the prior year. Adjusted EBITDA rose to $61.1 million from $55.0 million. Excluding approximately $2.3 million in fuel surcharges during the fourth quarter, adjusted EBITDA would have been $63.4 million. Chairman and Chief Executive Officer Irwin D. Simon stated that fiscal 2026 marks an important milestone, demonstrating the strength of the diversified global platform built over the last five years.

Segment Performance

Beverage revenue grew 6% to $254.0 million, bolstered by the acquisition of BrewDog which created a pro forma global beverage platform of approximately $500 million. The distribution segment saw the strongest growth, with revenue increasing 21% to $327.2 million and gross profit rising 39% to $40.7 million. International medical cannabis revenue increased 34%, reinforcing Tilray’s leadership across Europe. Cannabis net revenue rose 8% to $268.3 million, while wellness revenue increased 9% to $65.9 million.

Balance Sheet and Cash Flow

Tilray strengthened its balance sheet, ending the year with approximately $235 million in cash, restricted cash, and marketable securities. Net debt was reduced to $0.7 million. Positive cash flow from operations, excluding working capital, improved by 157% to approximately $18.2 million. For fiscal 2027, management expects adjusted EBITDA of $68 million to $75 million, reflecting continued momentum and disciplined capital allocation.

Market Context and Technicals

Despite the positive revenue beat, Tilray Brands faces significant headwinds in its stock valuation. The company has a market capitalization of $497.53 million, with a 52-week high of $23.20 and a 52-week low of $3.80. The Relative Strength Index (RSI) stands at 32.82, indicating oversold conditions. The stock has dropped 42.43% over the past 12 months and is currently trading near the lower end of its 52-week range. Benzinga’s Edge Stock Rankings indicate a negative price trend across all time frames, suggesting elevated risk and a need for stronger recovery signs before investor confidence improves.

What the Numbers Show

The divergence between GAAP net loss and positive adjusted net income highlights the impact of significant non-cash charges, particularly stock-based compensation ($45.9 million) and amortization ($67.6 million). While revenue growth is robust, the beverage segment’s gross margin declined from 39% to 36%, suggesting integration costs or cost pressures following the BrewDog acquisition that may require monitoring in future quarters.

Tilray Brands reported fourth-quarter adjusted earnings per share (EPS) of $0.05, beating the analyst consensus estimate of $(0.01) by 600 percent. This result represents a turnaround from the estimated loss, although it marks a 75 percent decrease from the $0.20 per share reported in the same period last year. The company also reported quarterly sales of $281.714 million, which beat the analyst consensus estimate of $246.377 million by 14.34 percent. This revenue figure reflects a 25.47 percent increase over sales of $224.535 million recorded in the same period last year.

Financial Performance Overview

The company’s ability to beat earnings estimates while reporting a significant year-over-year decline in EPS highlights a divergence between market expectations and prior-year performance. While the absolute EPS figure dropped substantially compared to the previous year, the beat against the negative consensus indicates improved operational efficiency or cost management relative to analyst forecasts.

What the Numbers Show

The data reveals a distinct split between top-line growth and bottom-line profitability trends. While sales grew robustly at 25.47% year-over-year, driven by strong demand or expanded market presence, the net profitability per share contracted sharply by 75% compared to the prior year. This suggests that while revenue generation is accelerating, cost structures or other expenses may have increased disproportionately, eroding margins relative to the previous year’s performance. However, the significant beat against the negative earnings estimate suggests that these pressures were less severe than analysts had anticipated.